Recent Content
- Salvage Therapy for Amyloidosis in Multiple Myeloma: Agents and Anti-Fibril Therapy
- Myeloma research on the move
- Dr. van Rhee on the Clinical Implications of CAR T-Cell Therapy in Relapsed/Refractory Myeloma
- Dr. Patel on Mitigating CAR T-Cell Therapy–Related CRS in Multiple Myeloma
- Dr. Baljevic on the FDA Approval of the ICARIA-MM Regimen in Relapsed/Refractory Multiple Myeloma
- Dr. Anderson on the Challenges Faced With CAR T-Cell Therapy in Myeloma
- Vertebroplasty in patients with multiple myeloma with vertebral compression fractures: protocol for a single-blind randomised controlled trial
- Dr. Shah on the Current State of Cellular Therapy in Multiple Myeloma
- Updates in Sequencing Treatment for Early Multiple Myeloma Relapse
- Dr. Shah on Unmet Needs With CAR T-Cell Therapy in Multiple Myeloma